Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹26,280.00
215.00 (0.82%)
Medium VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹55.84K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹25,150+4.5%
52W High₹37,000-29.0%
Current Price
₹26,280.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹21,024.00
Upper Circuit₹31,536.00
Reference Price
₹26,280.00
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹27010.0
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹26915.0
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -41.14 (SELL) with 81.2% confidence
MACD(12,26,9): Bearish crossover, Downward trend (below zero). Hist: growing (accelerating momentum)
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
81%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
26529.21
EMA50
26551.58
EMA200
28296.68
Price Action
MIXED
NEUTRAL
Higher Highs2
Higher Lows4
Lower Highs6
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹27100.00
₹27430.00
₹28456.67
₹29155.00
₹29587.50
Support (Below)
₹26268.00
₹25720.00
₹25240.83
Volume Analysis
TrendDECREASING
Change-21.40%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹26017.20
3% Risk₹25491.60
5% Risk₹24966.00
7% Risk (Custom)
₹24440.40Technical Levels
1x ATR (Volatility)₹25688.70
2x ATR (Swing)₹25097.40
3x ATR (Trend)₹24506.10
Immediate Support₹26268.00
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,602.4 Cr | ₹1,738.4 Cr | ₹1,757.2 Cr | ₹1,724 Cr |
| Net Profit | ₹367 Cr | ₹365.9 Cr | ₹415.3 Cr | ₹376 Cr |
| EPS | — | ₹172.17 | ₹195.42 | ₹176.92 |
| Operating Profit | ₹504.6 Cr | ₹518.4 Cr | ₹572.1 Cr | ₹533.2 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 25 Jul 2025 | Dividend - Rs 475 Per Share | DIVIDEND |
| 19 Jul 2024 | Dividend - Rs 410 Per Share | DIVIDEND |
| 21 Jul 2023 | Dividend - Rs 180 Per Share/ Special Dividend Rs 145 Per Share | SPECIAL_DIVIDEND |
| 02 Aug 2022 | Annual General Meeting/Dividend - Rs 145 Per Share/Special Dividend- 130 Per Share | AGM |
| 19 Jul 2021 | Annual General Meeting/Dividend - Rs 120 Per Share Special Dividend 155 Per Share | AGM |
Board Meetings
Upcoming and past meetings
| Date | Purpose | Links |
|---|---|---|
| 25 Sept 2002 | Unaudited Financial Results | - |
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ABBOTINDIA
View AllNEWS
positive
Business Standard - Markets 9d ago
Abbott India Ltd drops for fifth straight session
Abbott India Ltd is quoting at Rs 26020, down 1.03% on the day as on 13:19 IST on the NSE. The stock jumped 5.41% in last one year as compared to a 5.65% slide in NIFTY and a 11.71% spurt in the Nifty Pharma index.
ABBOTINDIAAONELIQUIDAONENIFTYAONETMMQ50AONETOTALBANKIETFPHARMABEESPVTBANIETFFinancial ServicesFINANCIAL SERVICES
NEWS
positive
Business Standard - Markets 32d ago
Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter
Abbott India has reported 7.6% increase in consolidated net profit to Rs 394.93 crore on a 6.5% rise in revenue to Rs 1,709.51 crore in Q4 FY26 as compared with Q4 FY25.
ABBOTINDIAHealthcare
NEWS
positive
Business Standard - Markets 32d ago
Abbott India standalone net profit rises 7.60% in the March 2026 quarter
Sales rise 6.54% to Rs 1709.51 crore
ABBOTINDIAHealthcare